BioLineRx's IFRS loss for 2021 was $27.054 million, down 9.9 percent from $30.021 million in the previous year.
BioLineRx's IFRS loss for 2021 was $27.054 million, down 9.9 percent from $30.021 million in the previous year.
BioLineRx reported for 2021
BioLineRx's IFRS loss for 2021 was $27.054 million, down 9.9 percent from $30.021 million in the previous year. Source: 
ir.biolinerx.com
ir.biolinerx.com
English (US) 